KURA - Kura Oncology - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KURA is currently covered by 10 analysts with an average price target of $19.39. This is a potential upside of $13.43 (225.34%) from yesterday's end of day stock price of $5.96.

Kura Oncology's activity chart (see below) currently has 81 price targets and 105 ratings on display. The stock rating distribution of KURA is 94.12% BUY and 5.88% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 42.58% with an average time for these price targets to be met of 255.56 days.

Highest price target for KURA is $40, Lowest price target is $10, average price target is $25.13.

Most recent stock forecast was given by LI WATSEK from CANTOR FITZGERALD on 26-Jun-2025. First documented stock forecast 16-Dec-2015.

Currently out of the existing stock ratings of KURA, 48 are a BUY (94.12%), 3 are a HOLD (5.88%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

1 months 15 days ago
(26-Jun-2025)

0/4 (0%)

$20.04 (201.20%)

Buy

$36

$30.04 (504.03%)

$36

1 months 21 days ago
(20-Jun-2025)

5/15 (33.33%)

$30.15 (515.38%)

376

Buy

$28

$22.04 (369.80%)

$28

2 months 6 days ago
(04-Jun-2025)

2/11 (18.18%)

$21.55 (334.11%)

296

Buy

$11

$5.04 (84.56%)

$32

3 months 8 days ago
(02-May-2025)

3/6 (50%)

$4.53 (70.02%)

64

Buy

$40

$34.04 (571.14%)

$40

3 months 13 days ago
(28-Apr-2025)

6/28 (21.43%)

$33.49 (514.44%)

372

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KURA (Kura Oncology) average time for price targets to be met?

On average it took 255.56 days on average for the stock forecasts to be realized with a an average price target met ratio 42.58

Which analyst has the current highest performing score on KURA (Kura Oncology) with a proven track record?

KONSTANTINOS APRILAKIS

Which analyst has the most public recommendations on KURA (Kura Oncology)?

Konstantinos Aprilakis has 10 price targets and 6 ratings on KURA

Which analyst is the currently most bullish on KURA (Kura Oncology)?

Konstantinos Aprilakis with highest potential upside - $35.88

Which analyst is the currently most reserved on KURA (Kura Oncology)?

Li Watsek with lowest potential downside - -$0

Kura Oncology in the News

Kura Oncology (KURA) Reports Q2 Loss, Lags Revenue Estimates

Kura Oncology (KURA) came out with a quarterly loss of $0.75 per share versus the Zacks Consensus Estimate of $0.15. This compares to a loss of $0.59 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -600.00%. A quarter ago, it was expected that...

Kura Oncology to Report Second Quarter 2025 Financial Results

SAN DIEGO, July 31, 2025 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced it will report second quarter 2025 financial results after the close of U.S. financial markets on Thursday, August 7, 2025. Kura’s management will...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?